Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Nucor Corporation (NUE - Analyst Report) provided its outlook for the third quarter ending September 29, 2012. The company expects earnings to be in the range of 30 cents to 35 cents per share in the quarter, down from 57 cents per share earned in the year-ago quarter.
Nucor expects lower earnings in the third quarter due to the negative impact of approximately $26 million or 5 cents per share in inventory purchase accounting adjustments related to the acquisition of Skyline Steel LLC and a loss of $17.6 million or 4 cents on the sale of Nucor Wire Products Pennsylvania Inc assets. The company expects that the third quarter results will also include estimated LIFO credit of $80.0 million or 16 cents.
Nucor expects lower profitability at its steel mills due to continued increase in steel imports and sluggish economy. Meanwhile, volatility in scrap prices, along with a combination of political and economic uncertainty, has also disrupted supply stocking levels.
Nucor released its second quarter 2012 financial results in July 2012. The company reported adjusted (excluding special items) earnings of 43 cents per share in the quarter, missing the Zacks Consensus Estimate of 47 cents.
A sticky situation in Europe forced Nucor to incur an impairment charge of $30 million associated with its Duferdofin Nucor S.r.l. joint venture as utilization rates continued to remain depressed and lagged the budgeted levels through the first half of the year. The adjusted earnings excluded cost associated with the Skyline Steel buyout and a one-time gain.
Profit, as reported, dropped substantially by 63% to $112.3 million or 35 cents a share from $299.8 million 94 cents reported a year ago. Oversupply in the industry and a gloomy European market hurt Nucor’s bottom line in the quarter.
Even though shipments to outside customers increased 6% year over year to 5,925,000 tons, a 6% fall in average sales price constrained Nucor’s revenues. As a result, consolidated net sales dipped to $5.10 billion in the quarter from $5.11 billion in the same period last year, but managed to brush past the Zacks Consensus Estimate of $5.07 billion.
The company, which competes with Commercial Metals Co. (CMC - Snapshot Report) and United States Steel Corp. (X - Analyst Report), maintains a Zacks #3 Rank, which translates into a short-term (1 to 3 months) Hold rating. We currently have a long-term Neutral recommendation on the shares of Nucor.
Get the full Analyst Report on X - FREE
Get the full Analyst Report on NUE - FREE
Get the full Snapshot Report on CMC - FREE